Skip to content

Comparison of two techniques of plasma exchange in kidney disorders in children

Centrifugal Vs Membrane technique of plasma exchange in nephrological indications in pediatric patients

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070212
Enrollment
20
Registered
2024-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N171- Acute kidney failure with acute cortical necrosis

Interventions

Intervention1: centrifugal plasma exchange: Plasma exchange procedure by centrifugal technique- Plasma exchange (PE) shall be performed at the bedside on the enrolled patients in the Nephrology ward (

Sponsors

PGIMERChandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with nephrological indications admitted to the nephrology ward of the Department of Pediatrics, Advanced Pediatrics Center requiring plasma exchange as part of the treatment (for conditions like ANCA associated rapidly progressive Glomerulonephritis, Anti-glomerular basement membrane diseases (Anti-GBM disease), Lupus Nephritis, Focal segmental glomerulosclerosis (FSGS), Atypical hemolytic uremic syndrome, Thrombotic thrombocytopenic purpura, Drug-associated thrombotic microangiopathy) 2. Age upto 12 years 3. Parents/Guardians willing to give consent for plasma exchange procedures

Exclusion criteria

Exclusion criteria: 1. Known allergy to plasma, Protamine or Heparin 2. Hemodynamically unstable patients 3. Severe systemic illness like HIV, HBV, HCV 4. Evidence of septicemia

Design outcomes

Primary

MeasureTime frame
a)Mean of percentage Plasma removal efficiency at the end of 5 procedures b)Comparison of change in mean hematological, biochemical, and coagulation profile after completing 5 procedures in two groups. Timepoint: Day 0, Day5 or Day 10 ( after 5 Procedures) and day 30

Secondary

MeasureTime frame
a) Percentage of adverse events in two groups. b) Percentage of patients alive on day 30 in two groups. Timepoint: After every procedure Day 30

Countries

India

Contacts

Public ContactNeha

PGIMER,CHANDIGARH

drhansrekha@gmail.com09855351450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026